Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56780

1.

Lack of Replication of the GRIN2A-by-Coffee Interaction in Parkinson Disease.

Ahmed I, Lee PC, Lill CM, Searles Nielsen S, Artaud F, Gallagher LG, Loriot MA, Mulot C, Nacfer M, Liu T, Biernacka JM, Armasu S, Anderson K, Farin FM, Funch Lassen C, Hansen J, Olsen JH, Bertram L, Maraganore DM, Checkoway H, Ritz B, Elbaz A.

PLoS Genet. 2014 Nov 20;10(11):e1004788. doi: 10.1371/journal.pgen.1004788. eCollection 2014 Nov. No abstract available.

PMID:
25412286
[PubMed - as supplied by publisher]
2.

Glutamate Receptor Gene GRIN2A, Coffee, and Parkinson Disease.

Hamza TH, Hill-Burns EM, Scott WK, Vance JM, Factor SA, Zabetian CP, Payami H.

PLoS Genet. 2014 Nov 20;10(11):e1004774. doi: 10.1371/journal.pgen.1004774. eCollection 2014 Nov. No abstract available.

PMID:
25411979
[PubMed - as supplied by publisher]
3.

CSF biomarkers and clinical progression of Parkinson disease.

Hall S, Surova Y, Ohrfelt A, Zetterberg H, Lindqvist D, Hansson O.

Neurology. 2014 Nov 19. pii: 10.1212/WNL.0000000000001098. [Epub ahead of print]

PMID:
25411441
[PubMed - as supplied by publisher]
4.

Neural substrates of levodopa-responsive gait disorders and freezing in advanced Parkinson's disease: A kinesthetic imagery approach.

Maillet A, Thobois S, Fraix V, Redouté J, Le Bars D, Lavenne F, Derost P, Durif F, Bloem BR, Krack P, Pollak P, Debû B.

Hum Brain Mapp. 2014 Nov 19. doi: 10.1002/hbm.22679. [Epub ahead of print]

PMID:
25411130
[PubMed - as supplied by publisher]
5.

Syntaxin 5-Dependent Retrograde Transport to the Golgi is Required for AAV Transduction.

Nonnenmacher ME, Cintrat JC, Gillet D, Weber T.

J Virol. 2014 Nov 19. pii: JVI.02520-14. [Epub ahead of print]

PMID:
25410859
[PubMed - as supplied by publisher]
6.

Specificity and sensibility of 9-Itens Wearing-off Questionnaire in Brazilian Parkinson disease patient sample.

Santos JG, Chien HF, Barbosa ER.

Arq Neuropsiquiatr. 2014 Nov;72(11):867-873.

PMID:
25410454
[PubMed - as supplied by publisher]
7.

Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases.

Berezin V, Walmod PS, Filippov M, Dityatev A.

Prog Brain Res. 2014;214C:353-388. doi: 10.1016/B978-0-444-63486-3.00015-3.

PMID:
25410365
[PubMed - as supplied by publisher]
8.

Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.

De Miranda BR, Popichak KA, Hammond SL, Miller JA, Safe S, Tjalkens RB.

Toxicol Sci. 2014 Nov 17. pii: kfu236. [Epub ahead of print]

PMID:
25406165
[PubMed - as supplied by publisher]
9.

Large diameter metal on metal total hip replacement for femoral neck fractures with neurological conditions: A retrospective assessment.

Li J, Zheng W, Zhao J, Liu D, Xu W.

Indian J Orthop. 2014 Nov;48(6):605-11. doi: 10.4103/0019-5413.144236.

PMID:
25404774
[PubMed]
Free PMC Article
10.

Role of Glucose Metabolism and ATP in Maintaining PINK1 Levels During Parkin-mediated Mitochondrial Damage Responses.

Lee S, Zhang C, Liu X.

J Biol Chem. 2014 Nov 17. pii: jbc.M114.606798. [Epub ahead of print]

PMID:
25404737
[PubMed - as supplied by publisher]
Free Article
11.

Parkinson disease: SNCA genetic variability and head injury could jointly increase the risk for PD.

[No authors listed]

Nat Rev Neurol. 2014 Nov 18. doi: 10.1038/nrneurol.2014.221. [Epub ahead of print] No abstract available.

PMID:
25404517
[PubMed - as supplied by publisher]
12.

Parkinson disease: Deep brain stimulation does not provide long-term benefit to postural and gait disturbances in Parkinson disease.

[No authors listed]

Nat Rev Neurol. 2014 Nov 18. doi: 10.1038/nrneurol.2014.222. [Epub ahead of print] No abstract available.

PMID:
25404514
[PubMed - as supplied by publisher]
13.

Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.

McKeon JE, Sha D, Li L, Chin LS.

Cell Mol Life Sci. 2014 Nov 18. [Epub ahead of print]

PMID:
25403879
[PubMed - as supplied by publisher]
14.

Evaluation of cutoff scores for the Parkinson's disease sleep scale-2.

Suzuki K, Miyamoto T, Miyamoto M, Suzuki S, Numao A, Watanabe Y, Tatsumoto M, Sakuta H, Watanabe Y, Fujita H, Iwanami M, Sada T, Kadowaki T, Hashimoto K, Trenkwalder C, Hirata K.

Acta Neurol Scand. 2014 Nov 17. doi: 10.1111/ane.12347. [Epub ahead of print]

PMID:
25402773
[PubMed - as supplied by publisher]
15.

Higher Frequency of Certain Cancers in LRRK2 G2019S Mutation Carriers With Parkinson Disease: A Pooled Analysis.

Agalliu I, San Luciano M, Mirelman A, Giladi N, Waro B, Aasly J, Inzelberg R, Hassin-Baer S, Friedman E, Ruiz-Martinez J, Marti-Masso JF, Orr-Urtreger A, Bressman S, Saunders-Pullman R.

JAMA Neurol. 2014 Nov 17. doi: 10.1001/jamaneurol.2014.1973. [Epub ahead of print]

PMID:
25401981
[PubMed - as supplied by publisher]
16.

Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease.

Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, Ruiz-Martínez J, Marti-Masso JF, Ferrer I, López de Munain A, Goldman SM, Schüle B, Langston JW, Aasly JO, Giordana MT, Bonifati V, Puschmann A, Canesi M, Pezzoli G, Maues De Paula A, Hasegawa K, Duyckaerts C, Brice A, Stoessl AJ, Marras C.

JAMA Neurol. 2014 Nov 17. doi: 10.1001/jamaneurol.2014.2704. [Epub ahead of print]

PMID:
25401511
[PubMed - as supplied by publisher]
17.

A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.

Muona M, Berkovic SF, Dibbens LM, Oliver KL, Maljevic S, Bayly MA, Joensuu T, Canafoglia L, Franceschetti S, Michelucci R, Markkinen S, Heron SE, Hildebrand MS, Andermann E, Andermann F, Gambardella A, Tinuper P, Licchetta L, Scheffer IE, Criscuolo C, Filla A, Ferlazzo E, Ahmad J, Ahmad A, Baykan B, Said E, Topcu M, Riguzzi P, King MD, Ozkara C, Andrade DM, Engelsen BA, Crespel A, Lindenau M, Lohmann E, Saletti V, Massano J, Privitera M, Espay AJ, Kauffmann B, Duchowny M, Møller RS, Straussberg R, Afawi Z, Ben-Zeev B, Samocha KE, Daly MJ, Petrou S, Lerche H, Palotie A, Lehesjoki AE.

Nat Genet. 2014 Nov 17. doi: 10.1038/ng.3144. [Epub ahead of print]

PMID:
25401298
[PubMed - as supplied by publisher]
18.

ATF3 Protects Pulmonary Resident Cells from Acute Lung Injury by Preventing Keap-1-mediated Nrf2 Degradation in a DJ-1-dependent manner.

Shan Y, Akram A, Amatullah H, Zhou DY, Gali P, Maron-Gutierrez T, González-López A, Zhou L, Rocco PR, Hwang D, Albaiceta GM, Haitsma JJ, Dos Santos CC.

Antioxid Redox Signal. 2014 Nov 17. [Epub ahead of print]

PMID:
25401197
[PubMed - as supplied by publisher]
19.

Treatment of depression in an adolescent with cardiomyopathy and arrhythmia.

Tanidir C, Tanidir IC, Tuzcu V.

Cardiol Young. 2014 Nov 17:1-3. [Epub ahead of print]

PMID:
25400066
[PubMed - as supplied by publisher]
20.

Multi-site videoconferencing for home-based education of older people with chronic conditions: the Telehealth Literacy Project.

Banbury A, Parkinson L, Nancarrow S, Dart J, Gray L, Buckley J.

J Telemed Telecare. 2014 Oct;20(7):353-9. doi: 10.1177/1357633X14552369.

PMID:
25399994
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk